Header Logo

Connection

RADEK SKODA to Primary Myelofibrosis

Back to Details
This is a "connection" page, showing publications RADEK SKODA has written about Primary Myelofibrosis.
RADEK SKODA
Connection Strength
4.062
Primary Myelofibrosis
  1. Genetic basis and molecular profiling in myeloproliferative neoplasms. Blood. 2023 04 20; 141(16):1909-1921.
    View in: PubMed
    Score: 0.807
  2. Inhibition of interleukin-1? reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm. Nat Commun. 2022 09 13; 13(1):5346.
    View in: PubMed
    Score: 0.774
  3. [Myeloproliferative neoplasms - Update on diagnosis and treatment]. Ther Umsch. 2019; 76(9):487-495.
    View in: PubMed
    Score: 0.599
  4. Accelerating myelofibrosis through loss of Dnmt3a. Blood. 2018 12 27; 132(26):2703-2704.
    View in: PubMed
    Score: 0.598
  5. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005 Apr 28; 352(17):1779-90.
    View in: PubMed
    Score: 0.232
  6. Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis. Nat Commun. 2023 10 12; 14(1):6414.
    View in: PubMed
    Score: 0.209
  7. Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs. Blood Adv. 2022 09 13; 6(17):5171-5183.
    View in: PubMed
    Score: 0.193
  8. HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. Nat Commun. 2018 04 12; 9(1):1431.
    View in: PubMed
    Score: 0.142
  9. Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency. Blood. 2016 06 23; 127(25):3253-9.
    View in: PubMed
    Score: 0.124
  10. Hereditary thrombocytosis not as innocent as thought? Development into acute leukemia and myelofibrosis. Blood. 2010 Oct 28; 116(17):3375-6.
    View in: PubMed
    Score: 0.085
  11. Thrombocytosis. Hematology Am Soc Hematol Educ Program. 2009; 159-67.
    View in: PubMed
    Score: 0.075
  12. NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? Leukemia. 2008 Jul; 22(7):1459-63.
    View in: PubMed
    Score: 0.070
  13. Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice. Blood. 2008 Apr 15; 111(8):3931-40.
    View in: PubMed
    Score: 0.070
  14. Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera. Leukemia. 2025 May; 39(5):1135-1145.
    View in: PubMed
    Score: 0.058
  15. Dkk3 levels in patients with myeloproliferative neoplasms. Thromb Res. 2014 Feb; 133(2):218-21.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.